-
2
-
-
27744523816
-
Histopathology, cell proliferation indices and clinical outcome in 304 patients with mantle cell lymphoma (MCL): a clinicopathological study from the European MCL Network
-
Tiemann M, Schrader C, Klapper W, et al. Histopathology, cell proliferation indices and clinical outcome in 304 patients with mantle cell lymphoma (MCL): a clinicopathological study from the European MCL Network. Br J Haematol 2005; 131: 29-38.
-
(2005)
Br J Haematol
, vol.131
, pp. 29-38
-
-
Tiemann, M.1
Schrader, C.2
Klapper, W.3
-
3
-
-
34250196140
-
Leukemic involvement is a common feature in mantle cell lymphoma
-
Ferrer A, Salaverria I, Bosch F, et al. Leukemic involvement is a common feature in mantle cell lymphoma. Cancer 2007; 109: 2473-2480.
-
(2007)
Cancer
, vol.109
, pp. 2473-2480
-
-
Ferrer, A.1
Salaverria, I.2
Bosch, F.3
-
4
-
-
0036791667
-
Cerebrospinal fluid involvement in mantle cell lymphoma
-
Valdez R, Kroft SH, Ross CW, et al. Cerebrospinal fluid involvement in mantle cell lymphoma. Mod Pathol 2002; 15: 1073-1079.
-
(2002)
Mod Pathol
, vol.15
, pp. 1073-1079
-
-
Valdez, R.1
Kroft, S.H.2
Ross, C.W.3
-
5
-
-
39049105188
-
Central nervous system involvement in mantle cell lymphoma
-
Ferrer A, Bosch F, Villamor N, et al. Central nervous system involvement in mantle cell lymphoma. Ann Oncol 2008; 19: 135-141.
-
(2008)
Ann Oncol
, vol.19
, pp. 135-141
-
-
Ferrer, A.1
Bosch, F.2
Villamor, N.3
-
6
-
-
70349207134
-
Mantle cell lymphoma with central nervous system involvement: frequency and clinical features
-
Gill S, Herbert KE, Prince HM, et al. Mantle cell lymphoma with central nervous system involvement: frequency and clinical features. Br J Haematol 2009; 147: 83-88.
-
(2009)
Br J Haematol
, vol.147
, pp. 83-88
-
-
Gill, S.1
Herbert, K.E.2
Prince, H.M.3
-
7
-
-
0033012454
-
Central nervous system involvement in patients with mantle cell lymphoma
-
Oinonen R, Franssila K, Elonen E. Central nervous system involvement in patients with mantle cell lymphoma. Ann Hematol 1999; 78: 145-149.
-
(1999)
Ann Hematol
, vol.78
, pp. 145-149
-
-
Oinonen, R.1
Franssila, K.2
Elonen, E.3
-
9
-
-
77951453410
-
Molecular remission is an independent predictor of clinical outcome in patients with mantle cell lymphoma after combined immunochemotherapy: a European MCL intergroup study
-
Pott C, Hoster E, Delfau-Larue MH, et al. Molecular remission is an independent predictor of clinical outcome in patients with mantle cell lymphoma after combined immunochemotherapy: a European MCL intergroup study. Blood 2010; 115: 3215-3223.
-
(2010)
Blood
, vol.115
, pp. 3215-3223
-
-
Pott, C.1
Hoster, E.2
Delfau-Larue, M.H.3
-
10
-
-
20144388941
-
Early consolidation by myeloablative radiochemotherapy followed by autologous stem cell transplantation in first remission significantly prolongs progression-free survival in mantle-cell lymphoma: results of a prospective randomized trial of the European MCL Network
-
Dreyling M, Lenz G, Hoster E, et al. Early consolidation by myeloablative radiochemotherapy followed by autologous stem cell transplantation in first remission significantly prolongs progression-free survival in mantle-cell lymphoma: results of a prospective randomized trial of the European MCL Network. Blood 2005; 105: 2677-2684.
-
(2005)
Blood
, vol.105
, pp. 2677-2684
-
-
Dreyling, M.1
Lenz, G.2
Hoster, E.3
-
11
-
-
20144376591
-
Immunochemotherapy with rituximab and cyclophosphamide, doxorubicin, vincristine, and prednisone significantly improves response and time to treatment failure, but not long-term outcome in patients with previously untreated mantle cell lymphoma: results of a prospective randomized trial of the German Low Grade Lymphoma Study Group (GLSG)
-
Lenz G, Dreyling M, Hoster E, et al. Immunochemotherapy with rituximab and cyclophosphamide, doxorubicin, vincristine, and prednisone significantly improves response and time to treatment failure, but not long-term outcome in patients with previously untreated mantle cell lymphoma: results of a prospective randomized trial of the German Low Grade Lymphoma Study Group (GLSG). J Clin Oncol 2005; 23: 1984-1992.
-
(2005)
J Clin Oncol
, vol.23
, pp. 1984-1992
-
-
Lenz, G.1
Dreyling, M.2
Hoster, E.3
-
12
-
-
33746605975
-
A chromosomal translocation in cyclin D1-negative/cyclin D2-positive mantle cell lymphoma fuses the CCND2 gene to the IGK locus
-
Gesk S, Klapper W, Martin-Subero JI, et al. A chromosomal translocation in cyclin D1-negative/cyclin D2-positive mantle cell lymphoma fuses the CCND2 gene to the IGK locus. Blood 2006; 108: 1109-1110.
-
(2006)
Blood
, vol.108
, pp. 1109-1110
-
-
Gesk, S.1
Klapper, W.2
Martin-Subero, J.I.3
-
13
-
-
33644786965
-
Quantitative assessment of molecular remission after high-dose therapy with autologous stem cell transplantation predicts longterm remission in mantle cell lymphoma
-
Pott C, Schrader C, Gesk S, et al. Quantitative assessment of molecular remission after high-dose therapy with autologous stem cell transplantation predicts longterm remission in mantle cell lymphoma. Blood 2006; 107: 2271-2278.
-
(2006)
Blood
, vol.107
, pp. 2271-2278
-
-
Pott, C.1
Schrader, C.2
Gesk, S.3
-
14
-
-
38349104577
-
A new prognostic index (MIPI) for patients with advanced-stage mantle cell lymphoma
-
Hoster E, Dreyling M, Klapper W, et al. A new prognostic index (MIPI) for patients with advanced-stage mantle cell lymphoma. Blood 2008; 111: 558-565.
-
(2008)
Blood
, vol.111
, pp. 558-565
-
-
Hoster, E.1
Dreyling, M.2
Klapper, W.3
-
15
-
-
24644432553
-
Report of an international workshop to standardize baseline evaluation and response criteria for primary CNS lymphoma
-
Abrey LE, Batchelor TT, Ferreri AJ, et al. Report of an international workshop to standardize baseline evaluation and response criteria for primary CNS lymphoma. J Clin Oncol 2005; 23: 5034-5043.
-
(2005)
J Clin Oncol
, vol.23
, pp. 5034-5043
-
-
Abrey, L.E.1
Batchelor, T.T.2
Ferreri, A.J.3
-
16
-
-
33845382806
-
Nonparametric estimation from incomplete observations
-
Kaplan EL, Meier P. Nonparametric estimation from incomplete observations. J Am Stat Assoc 1958; 53: 457-481.
-
(1958)
J Am Stat Assoc
, vol.53
, pp. 457-481
-
-
Kaplan, E.L.1
Meier, P.2
-
17
-
-
49649088421
-
[18F]fluorodeoxyglucose positron emission tomography scanning for staging, response assessment, and disease surveillance in patients with mantle cell lymphoma
-
Gill S, Wolf M, Prince HM, et al. [18F]fluorodeoxyglucose positron emission tomography scanning for staging, response assessment, and disease surveillance in patients with mantle cell lymphoma. Clin Lymphoma Myeloma 2008; 8: 159-165.
-
(2008)
Clin Lymphoma Myeloma
, vol.8
, pp. 159-165
-
-
Gill, S.1
Wolf, M.2
Prince, H.M.3
-
18
-
-
57449089000
-
What is the real risk of central nervous system involvement in mantle cell lymphoma?
-
Gill S, Seymour JF. What is the real risk of central nervous system involvement in mantle cell lymphoma?. Leuk Lymphoma 2008; 49: 2237-2239.
-
(2008)
Leuk Lymphoma
, vol.49
, pp. 2237-2239
-
-
Gill, S.1
Seymour, J.F.2
-
19
-
-
79251532085
-
Flow cytometric immunophenotyping of cerebrospinal fluid specimens
-
Craig FE, Ohori NP, Gorrill TS, et al. Flow cytometric immunophenotyping of cerebrospinal fluid specimens. Am J Clin Pathol 2011; 135: 22-34.
-
(2011)
Am J Clin Pathol
, vol.135
, pp. 22-34
-
-
Craig, F.E.1
Ohori, N.P.2
Gorrill, T.S.3
-
20
-
-
77956971692
-
Clinical significance of occult cerebrospinal fluid involvement assessed by flow cytometry in non-Hodgkin's lymphoma patients at high risk of central nervous system disease in the rituximab era
-
Sancho JM, Orfao A, Quijano S, et al. Clinical significance of occult cerebrospinal fluid involvement assessed by flow cytometry in non-Hodgkin's lymphoma patients at high risk of central nervous system disease in the rituximab era. Eur J Haematol 2010; 85: 321-328.
-
(2010)
Eur J Haematol
, vol.85
, pp. 321-328
-
-
Sancho, J.M.1
Orfao, A.2
Quijano, S.3
-
21
-
-
19944428085
-
High incidence of occult leptomeningeal disease detected by flow cytometry in newly diagnosed aggressive B-cell lymphomas at risk for central nervous system involvement: the role of flow cytometry versus cytology
-
Hegde U, Filie A, Little RF, et al. High incidence of occult leptomeningeal disease detected by flow cytometry in newly diagnosed aggressive B-cell lymphomas at risk for central nervous system involvement: the role of flow cytometry versus cytology. Blood 2005; 105: 496-502.
-
(2005)
Blood
, vol.105
, pp. 496-502
-
-
Hegde, U.1
Filie, A.2
Little, R.F.3
-
22
-
-
0036332548
-
Intrathecal chemotherapy alone is inadequate central nervous system prophylaxis in patients with intermediategrade non-Hodgkin's lymphoma
-
Chua SL, Seymour JF, Streater J, et al. Intrathecal chemotherapy alone is inadequate central nervous system prophylaxis in patients with intermediategrade non-Hodgkin's lymphoma. Leuk Lymphoma 2002; 43: 1783-1788.
-
(2002)
Leuk Lymphoma
, vol.43
, pp. 1783-1788
-
-
Chua, S.L.1
Seymour, J.F.2
Streater, J.3
-
23
-
-
84859211271
-
CNS prophylaxis in diffuse large B-cell lymphoma: if, when, how and for whom?
-
Siegal T, Goldschmidt N. CNS prophylaxis in diffuse large B-cell lymphoma: if, when, how and for whom?. Blood Rev 2012; 26: 97-106.
-
(2012)
Blood Rev
, vol.26
, pp. 97-106
-
-
Siegal, T.1
Goldschmidt, N.2
|